These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2238561)

  • 1. Acid treatment of platelets as a simple procedure for distinguishing platelet-specific antibodies from anti-HLA antibodies: comparison with chloroquine treatment.
    Kurata Y; Oshida M; Take H; Furubayashi T; Mizutani H; Tomiyama Y; Yonezawa T; Tarui S
    Vox Sang; 1990; 59(2):106-11. PubMed ID: 2238561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the 'thrombocyte-specific' glycoproteins Ia/IIa, IIb, and IIb/IIIa.
    Neumüller J; Tohidast-Akrad M; Fischer M; Mayr WR
    Vox Sang; 1993; 65(3):223-31. PubMed ID: 8249366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to eliminate HLA class I antigens from platelet surface without cell damage: acid treatment at pH 3.0.
    Kurata Y; Oshida M; Take H; Furubayashi T; Nakao H; Tomiyama Y; Kanayama Y; Nagao N; Okubo Y; Yonezawa T
    Vox Sang; 1989; 57(3):199-204. PubMed ID: 2617955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple method for differentiating between HLA and platelet-specific antibodies by flow cytometry.
    Freedman J; Hornstein A
    Am J Hematol; 1991 Dec; 38(4):314-20. PubMed ID: 1746540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of platelet antigens after chloroquine treatment.
    Langenscheidt F; Kiefel V; Santoso S; Nau A; Mueller-Eckhardt C
    Eur J Haematol; 1989 Feb; 42(2):186-92. PubMed ID: 2465179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidified chloroquine treatment for the removal of class I HLA antigens.
    Srivastava A; Pearson H; Bryant J; Favaloro E; Coulits N; Jindra J; Wylie B
    Vox Sang; 1993; 65(2):146-50. PubMed ID: 7692675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of platelet serology in UK laboratories (1987): an assessment of the efficacy of using chloroquine-treated platelets to distinguish between platelet-specific and anti-HLA antibodies. The UK Platelet and Granulocyte Serology Working Group.
    Lucas GF
    Clin Lab Haematol; 1990; 12(2):185-200. PubMed ID: 2208949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test.
    Nordhagen R; Flaathen ST
    Vox Sang; 1985; 48(3):156-9. PubMed ID: 3885571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of anti-platelet antibodies in patients with chronic idiopathic thrombocytopenic purpura (ITP) using acid-treated, formalin-fixed platelets.
    Mizumoto Y; Fujimura Y; Nishikawa K; Uchida M; Fukui H; Morii T; Narita N; Kurata Y
    Am J Hematol; 1991 Aug; 37(4):274-6. PubMed ID: 1858787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immobilized platelet membrane glycoproteins for the detection of platelet-specific alloantibodies in solid-phase ELISA.
    Collins J; Aster RH
    Vox Sang; 1987; 53(3):157-61. PubMed ID: 3318122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective elution of HLA antigens and beta 2-microglobulin from human platelets by chloroquine diphosphate.
    Kao KJ
    Transfusion; 1988; 28(1):14-7. PubMed ID: 3277320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reactivity of platelet-specific and HLA antibodies with chloroquine-treated thrombocytes].
    Langenscheidt F; Kiefel V; Santoso S; Nau A; Mueller-Eckhardt C
    Beitr Infusionther Klin Ernahr; 1987; 18():382-4. PubMed ID: 3439998
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody.
    Kao KJ; Cook DJ; Scornik JC
    Blood; 1986 Sep; 68(3):627-32. PubMed ID: 3742047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA (class I) antigens on platelets are involved in platelet function.
    Cosgrove LJ; Vaughan HA; Tjandra JJ; Thurlow PJ; McKenzie IF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():69-77. PubMed ID: 3372006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet immunology. ELISA for detection of platelet antibodies, platelet-specific antigens and platelet glycoproteins.
    Taaning E
    Dan Med Bull; 1992 Aug; 39(4):343-54. PubMed ID: 1382006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet alloantibodies in transfused patients.
    Kiefel V; König C; Kroll H; Santoso S
    Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets retain function and can be stored following disruption of human leucocyte antigens.
    Davis AM; Rawson R; Pahn G; Daly J; Marks DC
    Vox Sang; 2024 Jul; 119(7):675-685. PubMed ID: 38596985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets as immunogens.
    Waters AH
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):637-41. PubMed ID: 1450332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransfusion purpura. Report of a case with anti-P1A1 masked by HLA antibodies.
    Dunstan RA; Rosse WF
    Transfusion; 1985; 25(3):219-22. PubMed ID: 3159134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.